At the Atlantic, the peerless @sarahzhang has been leading our coverage of COVID-19 vaccines. Here's a thread of her amazing work.
1) A great big-picture look at the Moderna & Pfizer vaccines, which also explains mRNA vaccines are. theatlantic.com/health/archive…
2) Here, Sarah looks at the results from the AstraZeneca/Oxford vaccine trial and why they're a little weirder and more confusing than those from the other two. theatlantic.com/health/archive…
3) Here, Sarah looks at the challenges posed by the transition between two administrations, and the problems that Biden may face as a result.
4) In this piece from September, Sarah presciently laid out a lot of the logistical challenges that lie between creating approved vaccines, and actually getting them into people's arms.
5) In this from July, Sarah makes a crucial point that can't be overstated enough: a vaccine is only the beginning of the end. Much has happened since she wrote this, but it's worth re-reading for a deeper understanding of what the next year will entail.
6) And in this piece from *May*, Sarah called a lot of the conspiracies and related issues that are about to become important problems in the year ahead.
All of this is to say that Sarah Zhang is an absolute superstar, and you should follow her, book her for your shows and podcasts, and pay attention to her work over the next several months for your vaccine-related questions. /End
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Some news: After 8 years & 750 stories, I've decided to leave The Atlantic. Today's my last day.
Being a writer means you can’t say things like "I can’t tell you what this means" cos, well, I can. That's kind of the point of me. So here’s an attempt at looking back & forward: 1/
I’m really proud of the work I did here. Hagfish. Lichens. Endlings. Source diversity. 60+ pandemic pieces. Long COVID especially. More important than the awards, I know this work helped people, and it changed my understanding of what journalism can do & whom it should serve. 2/
That work depended on a team. All my love to Sarah Laskow & Ross Andersen, dear friends & amazing editors; everyone on the sci/tech/health desk, still the best in the biz; and the indefatigable copy-edit, fact-check, art, audience & comms teams. 3/
🛑I wrote about what “fatigue” really means for people with long COVID and ME/CFS, and why this profoundly debilitating symptom is so often misunderstood and trivialized.
First, an important note. I’ve been told that this piece will be free to read for 24 hours, but will then go behind the paywall. Best I could do. If you’re not a subscriber and this is useful to you or your loved ones, I’d suggest saving a copy ASAP. 2/ theatlantic.com/health/archive…
When long-haulers talk about their fatigue, they often hear “Oh I’m tired too”. But theirs is utterly different to the everyday version healthy people get. More severe. Very hard to push through (& costly if you try). Not cured by sleep. Multifaceted. 3/ https://t.co/yqZoRGtyxAtheatlantic.com/health/archive…
👋I’m back. And I wrote about the current wave of attempts to downplay long COVID—less outright denial & more "it’s real but no big deal".
Except: it very much is. It’s a substantial and ongoing crisis that still demands our attention. 1/ theatlantic.com/health/archive…
This piece addresses the gaping flaws in the most common downplaying arguments. It covers biomarkers, disability claims, the spectrum of severity, the oft-repeated “I don’t’ know anyone with long COVID” line, and more. 2/ theatlantic.com/health/archive…
A key point: The flaws in these arguments become clear if you actually talk to long-haulers (& clinicians with extensive experience in treating them). Their experiences are the ground truth against which all other data must be understood. 3/ theatlantic.com/health/archive…
🧵Some personal news: I’m taking a 6-month sabbatical, starting now. These past 3 years have been the most professionally meaningful of my life, but they’ve also deeply broken me. The pandemic isn’t over, but after a long time spent staring into the sun, I need to blink. 1/
I’ve talked openly about the mental health challenges of pandemic reporting—e.g.
& traumastewardship.com/2022/02/ed-yon… I know stepping away is a huge privilege most people don’t have. Persistence matters, but it has limits, and I’ve long since reached mine. 2/
When I’ve interviewed healthcare workers & others about burnout, there are basically 3 roads they take. 1) Double down on duty and mission. 2) Find community. 3) Step away.
I’ve done the first for as long as I can. I’m now doing the third to focus on the second. 3/
🧵I want to share some thoughts about reporting on long COVID and other complex chronic illnesses. (e.g. below)
This is a thread about the ethos behind these pieces, and how I’ve approached interviewing, writing, and the rest of it. 1/
I still consider myself new to this kind of reporting & am learning as I go. This isn’t a finger-wagging lecture. I'm just sharing some stuff I've thought about a lot. I hope it will be helpful to other journalists who want to do this kind of work & inspire more to do so. 2/
And many (most?) of these ideas and principles also apply to other pieces I’ve written about people who’ve taken the brunt of the pandemic, including those grieving loved ones lost to COVID, immunocompromised folks, and burned-out healthcare workers. 3/
🚨I wrote about ME/CFS (chronic fatigue syndrome). The US has millions of people with it & maybe two dozen docs who specialize in it.
This medical crisis needs urgent attention, esp. now COVID has hugely increased the number of long-haulers. 1/ theatlantic.com/health/archive…
ME/CFS involves a panoply of debilitating symptoms that affect almost every organ system. People are intensely sick for years or decades. They spend much of that time getting stigmatized, dismissed, misdiagnosed. 2/ theatlantic.com/health/archive…
At the highest estimates, Americans with ME/CFS outnumber the populations of 15 individual states. But there aren’t enough ME/CFS specialists to fill a Major League baseball roster. Most patients never get a diagnosis, let alone any kind of care. 3/ theatlantic.com/health/archive…